| Control | CAD patients | P |
---|---|---|---|
 | (n = 15) | (n = 25) |  |
Gender | Â | Â | 0.7360 |
 Male (%) | 10 (67.70) | 18 (72.00) |  |
 Female (%) | 5 (32.30) | 7 (28.00) |  |
Age (years) | 64.73 ± 3.00 | 67.36 ± 2.00 | 0.3469 |
BMI, kg/m2 | 23.10 ± 0.43 | 22.53 ± 0.37 | 0.3289 |
SBP, mm Hg | 160.70 ± 4.00 | 161.00 ± 4.00 | 0.9438 |
DBP, mm Hg | 91.40 ± 3.00 | 92.80 ± 3.00 | 0.8707 |
Creatinine, μmol/L | 84.41 ± 6.17 | 109.6 ± 22.25 | 0.3943 |
Homocysteine, μmol/L | 10.9400 ± .73 | 16.3400 ± 1.47 | 0.004 |
fasting blood-glucose (mmol/L) | 7.06 ± 0.78 | 6.03 ± 0.40 | 0.1131 |
Triglyceride, ìmol/L | 2.45 ± 0.48 | 1.97 ± 0.24 | 0.3320 |
Total cholesterol, ìmol/L | 4.49 ± 0.24 | 4.53 ± 0.20 | 0.8967 |
LDL-C, mmol/L | 2.65 ± 0.31 | 2.80 ± 0.43 | 0.8966 |
Positive history of diabetes (%) | 5(40) | 4(16) | 0.2550 |
Positive history of smoking (%) | 3(20) | 9(36) | 0.4770 |
Positive history of drinking (%) | 3(20) | 11(44) | 0.1770 |